Oleg Kovalenko

Title: Oleg Kovalenko: Innovator in Binding Molecule Technology

Introduction

Oleg Kovalenko is a distinguished inventor based in Cambridge, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of binding molecules. With a total of four patents to his name, Kovalenko's work has the potential to impact various applications in medical and scientific research.

Latest Patents

Kovalenko's latest patents focus on a single domain specific binding molecule. The invention provides a structure defined as FW1-CDR1-FW2-HV2-FW3a-HV4-FW3b-CDR3-FW4. This structure includes Framework Regions FW1, FW2, FW3a, FW3b, and FW4, as well as Complementarity Determining Regions CDR1 and CDR3, and Hypervariable Regions HV2 and HV4. The amino acid sequences defined in these regions contribute to a high affinity anti-human serum albumin (HSA) binding domain.

Career Highlights

Throughout his career, Oleg Kovalenko has worked with notable institutions, including the University Court of the University of Aberdeen and Elasmogen Limited. His experience in these organizations has allowed him to refine his expertise in the field of binding molecules and their applications.

Collaborations

Kovalenko has collaborated with several professionals in his field, including Caroline Barelle and Mischa Roland Muller. These partnerships have further enhanced his research and development efforts.

Conclusion

Oleg Kovalenko is a prominent inventor whose work in binding molecule technology is paving the way for advancements in biotechnology. His innovative patents and collaborations reflect his commitment to scientific progress and innovation.